Selective aurora kinase inhibitors identified using a taxol-induced checkpoint sensitivity screen

Area of Science:

• Biochemistry
• Cell Biology
• Pharmacology

Background:

• Aurora kinases are crucial for cell cycle regulation and mitotic spindle assembly.
• These kinases are actively investigated as targets for novel anticancer therapies.

Purpose of the Study:

• To discover and characterize a new class of potent and selective Aurora kinase inhibitors.
• To identify key structural determinants for kinome-wide selectivity, particularly for Aurora A.

Main Methods:

• Phenotypic cellular screening to identify initial inhibitors.
• Structure-activity relationship studies guided by Aurora B co-crystal structure.
• Biochemical and cellular profiling of optimized compounds.

Main Results:

• Identification of a novel, highly potent, and selective Aurora kinase inhibitor class.
• Inhibitors induced endoreduplication, polyploidy, and cancer cell death.
• Discovery of a subseries with enhanced selectivity for Aurora A.
• Compounds 1 and 3 demonstrated valuable pharmacological profiles compared to existing inhibitors.

Conclusions:

• The newly discovered Aurora kinase inhibitors are potent and selective pharmacological tools.
• These compounds effectively inhibit Aurora kinase-dependent functions in cancer cells.
• Optimized inhibitors show potential for further development as anticancer agents.